Key result
Cancer cell lipid metabolism alters macrophage phenotypes to drive tumor progression, offering new therapeutic targets.
Why the study?
Identifying metabolic changes that govern the complex crosstalk between tumor cells and tumor-associated macrophages is an important step toward exploring novel therapies targeting immune cell metabolic reprogramming to overcome therapy resistance.
Understanding the lipid metabolic crosstalk between cancer cells and tumor-associated macrophages may provide new targets for antitumor therapies.
Answers are grounded in this paper and cite their sources.
Highlights potential macrophage targets in cancer; leaves open clinical validation of lipid metabolism interventions.
In the tumor microenvironment, tumor-associated macrophages (TAMs) are one of the most abundant cell populations, playing key roles in tumorigenesis, chemoresistance, immune evasion, and metastasis. There is an important interaction between TAMs and cancer cells: on the one hand, tumors control the function of infiltrating macrophages, contributing to reprogramming of TAMs, and on the other hand, TAMs affect the growth of cancer cells. This review focuses on lipid metabolism changes in the complex relationship between cancer cells and TAMs. We discuss how lipid metabolism in cancer cells affects macrophage phenotypic and metabolic changes and, subsequently, how altered lipid metabolism of TAMs influences tumor progression. Identifying the metabolic changes that influence the complex interaction between tumor cells and TAMs is also an important step in exploring new therapeutic approaches that target metabolic reprogramming of immune cells to enhance their tumoricidal potential and bypass therapy resistance. Our work may provide new targets for antitumor therapies.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a review in Cancer. Lipid metabolism changes was evaluated. Lipid metabolism changes in cancer cells affect macrophage phenotypic and metabolic changes, which subsequently influence tumor progression and may provide new targets for antitumor therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: